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Introduction
What can and should be done preoperatively to de

termine a hemorrhagic tendency, and how valuable are

the available substances in preventing excessive surgi
cal hemorrhage and post-operative oozing?

llany so-cal

led 'hemostatics' have been widely used in a desperate

attempt to control bleeding, without any attempt at de

termining the cause.

The author is proposing the idea that the cause of

most bleeding is a deficiency of one of the primary fac
tors in the mechanism of blood coagulation, and that

such deficiency can be easily identified preoperatively.
The various hemorrhagic conditions will be classified

according to these deficiencies, and the pathological

physiology explained; and an intelligent clinical method
for predicting a hemorrhagic tendency, and identifica

tion of the deficient factor, will be outlined.

Having given a method for such identification, then

rational preoperative treatment may be administered.

The substances available for such administration will be

discussed and evaluated, showing their physiological ac
tion where of proven value, availability, use, and ef

fectiveness, and also showing why many commercial pre

parations of claimed hemostatic properties are worthless
(1)

and should be discarded.

The value of diet as an ad-

junct in therapy will be explained.
The material to be used is not original, but nowhere in the literature did I find any such correlation
of the material to stress adequate preoperative prediction of a hemorrhagic tendency, and rational preoperative therapy.

(ii)

Present Conce.R!_ of Blood Coagulation
The first fragments of information that led to the
present concept of the mechanism involved in blood coagulation were recorded less than one hundred years ago.
Hewson (1) in 1770 observed that a solid separated from
blood when it clotted.

This substance still retains the

name, fibrin, first given it by Chaptal (1).

In 1845,

Buchanan (1) reported that serum after coagulation is capable of clotting exudates such as hydrocoele and pericardial fluids.

Dennis (1) a little later found that

when he saturated plasma with sodium chloride, he precipitated an albuminous material which on being redissolved
underwent spontaneous coagulation.
At this stage, Alexander Schmidt (1,2,5) entered the
field, and began his classical work.

He showed that the

agent present in serum which causes the production of
fibrin, is a definite substance whi ch he considered a ferment, and named thrombin.

His work , moreover, furnished

evidence that the blood contained an inactive precursor
of thrombin, prothrombin.

To Hammarsten (1,2,5) belongs

the credit of being the first to show that a specific
plasma protein, fibrinogen, yields fibrin when acted
upon by thrombin.

The next important advance was made

by Arthus and Pages, who discovered that the addition of
a soluble oxalate to blood prevented clotting, and fur-

(1)

thermore, that on recalcification normal coagulation
occurred.

These authors concluded that calcium was

necessary for the clotting of fibrinogen by thrombin.
This idea was never accepted by Schmidt, who held that
the oxalate acted merely as an inhibitor.

Hammarsten,

however, showed that although the oxalate could be completely removed by dialysis, no clotting occurred unless calcium was readded.

Pekelharing's studies (5) in-

dicated that calcium was necessary for the conversion
of prothrombin to thrombin, and thi s was confirmed by
Hammarsten, who further concluded that calcium was not
essential after thro mbin was formed.
The existance of another factor in coagulation was
suggested by Schmidt's finding that tissue extracts
greatly accelerated clotting.(1,2,5)

Morawitz and Fuld

and Spiro (5) recognized these tissue extracts as a specific agent in coagulation, the former author naming it
thrombokinase; the latter, cytozyme.

Morawitz, corre-

lating the findings of the earlier workers and of his
contemporaries, formulated the modern theory of blood
coagulation, which can be concisely expressed by two
equations:
1. Prothrombin

+ thrombokinase +calcium• thrombin.

2. Fibrinogen+ Thrombin
(2)

= fibrin.

Thus, two distinct reactions occur in the clotting of blood:

1, The formation of thrombin by the in-

teraction of the three substances mentioned; 2, the conversion of fibrinogen to insoluble fibrin by thrombin.
The thrombokinase or thromboplastin is supplied either
from the disintegrating platelets or from injured tissue cells.

This simple concept is now widely accepted

and serves as the basis of most present day research on
coagulation.

The nature of the reaction between proth-

rombin, thrombokinase, and calcium remains a debated
question.

Some assume a union of the three substances,

others look upon thrombokinase as a co-enzyme, or a catalyst acting on prothrombin.

Howell assuems that the

prothrombin is bound to an inhibitory substance, heparin,
which the tissue factor, thromboplastin, neutralizes,
whereupon the liberated prothrombin reacts with calcium
to become thrombin.

Bordet (3,5) postulates that a pre-

curson of prothrombin, proserozyme , exists in the blood.
Otherwise, his concept is essentially in accord with the
classical theory.

He assumes an act~al union of the pro-

thrombin with calcium and the lipoid cytozyme.

Pickering

(4,5) holds that the prothrombin is stabilized by the
colloidal plasma proteins, and that such factors as
' platelet debris and tissue extracts labilize the colloidal comple--x, allowing the prothrombin to be converted
into thrombin.
(3)

_It must be stated, however, that there are those
who do not conform to the thrombin theory.

Nolf (3)

looks upon thrombin as a product of coagulation and not
an active factor. · Hekma (3) considers the conversion
of fibrinogen to fibrin as essentially a reversible solgel transformation, with thrombin playing a rather subordinate role.

Perhaps the most confusing theory of all

was the one developed by Woolridge (4).

According to

this author, a tissue substance (which he calls tissue
fibrinogen) reacts with the fibrinogen of the blood to
form fibrin and thrombin.

Mills (3,5) has modified this

theory and assumes that two distinct clotting mechanisms
occur:

(1) the action of tissue fibrinogen on blood fib-

rinogen; (2) the actiont of thrombin on fibrinogen.

The

first reaction requires calcium and recent researches
s1l'ongly suggest that tissue fibrinogen is merely thromboplastin contaminated with prothrombin.
Most progress has been made by studies based on the
concept that thrombin is formed as the result of the interaction of prothrombin, thrombokinase, and calcium,
and that thrombin acts specifically on fibrinogen, converting it to fibrin.

While nearly all workers in the

field accept this theory, much disagreement exists in regard to the actual mechanisms of these two reactions.
It can readily be seen that according to this theory
(4)

only four primary factors are needed for clotting:
Prothrombin, Thrombokinase, Calcium, and Fibrinogen.
Thrombin is not a primary factor, but a resulting participant.

Obviously, a deficiency of any one of these

factors will wholly inhibit or markedly delay the coagulation of blood.

Therefore it is desirable to sum-

marize the most important facts known about these four
agents, and the recent developments, in order that their
significance in the various hemorrhagic conditions can
be fully understood.

Proth:rombin:

(Prothrombase, Th:rombogen, Serozyme)

This agent is the precursor or mother substance
of thrombin, the active coagulating enzyme.

It is be-

lieved to have the nature of a proenzyme, is closely
associated with the serum protein, globulin, is inac-

so 0 c.,

tivated at a temperature of

and is removed from

plasma by alumina c:ream, magnesium hydroxide, and other
similar adsorbing agents.

It is apparently found ex-

clusively in the plasma and is not derived from the
platelets as was formerly assumed.

The view of Howell

(1) that prothrombin is combined wi th an anttprothrombin similar to or identical with heparin has largely
been abandoned, especially since no evidence can be
found that the normal blood contains any anticoagulant
(5)

such as heparin.

Normally, this agent · is activated

by calcium and thrombokinase, but it can be directly
converted to thrombin by trypsin and by certain snake
venoms, as shown by Eagle (6) (see Thrombokinase).
Prothrombin is formed by the liver and it has been
proven by Almquist (7), Dam and Schonheyder (8), and
Quick (9,10,11), that the presence of Vitamin Kin the
liver is necessary for the synthesis of this agent.
The prothrombin content of normal blood is fairly
constant, and the amount present is greatly in excess
of the physiologic requirements.
Several simple methods of determination of prothrombin blood level have been developed which will be
discussed later in this paper.
Mellanby, Eagle (12), and Others (13) have been
able to prepare potent and stable preparations of both
prothrombin and thrombin.

Thrombokinase:

(Thromboplastin, Cytozyme, Tissue Extract,
Tissue Coagulant, Platelet Extract,
Platelet Factor)

This substance has the function of converting prothrombin into active thrombin.
ized calcium is essential.

In this reaction ion-

Whether thrombokinase mere-

ly activates prothrombin, or whether it actually unites
chemically is not known.

Recently Eagle and Harris (12)
(6)

have demonstrated that trypsin can change prothrombin to thrombin.

By removal of the pancreas a mark-

ed increase in coagulation time resulted, which was
not decreased on the injection of insulin (14).
creatic fistulas gave the same results.

Pan-

Then with ex-

perimentation with pure trypsin, Eagle decided that it
acts as a proteolytic enzyme, splitting off cephalin
from its inert protein combinations and making it available for the activation of thrombin.

All proteolytic

enzymes then may be considered thromoplastic enzymes,
their action consists in the mobilization of cephalin
and calcium at the colloidal surface of the protein
(prothrombin) substrate, where the close juxtaposition
of the three components permits of the formation of thrombin according to the plan outlined previously, that is,
by an intermediary prothrombin-calcium-cephalin complex.
(15).

These proteolytic enzymes are inactive without

calcium, but the exact mechanism of how activated by calcium has not yet been proved.

If we are to say then that

this substance in the normal blood is a proteolytic enzyme, then thrombokinase is a better term than thromboplastin.
Thrombokinase is widely distributed in the body as
an intracellular substance.

In the blood, it occurs

locked up in the platelets and probably also in the

(?)

leukocytes.

Certain tissues, notably the brain, lungs,

and thymus, are particularly rich in thrombokinase, although it is apparently present in some amount in all
tissue cells.

It appa:rently , never occurs free, but is

liberated whenever tissue cells are injured or ruptured.
In blood uncontaminated by tissue juices, the thrombokinase is derived solely from the p latelets.

The liber-

ation of thrombokinase from platelets, therefore appears
to be the prime factor in determining the clotting time
of blood obtained by venipuncture.

The slowness with

which thrombokinase is liberated is illustrated by this
simple experiment:

On placing 1 cc. of blood obtained

by venipunctur e in a small test tube, it will remain
liquid for four to eight minutes, whereas if the same
quantity of blood is mixed with a drop of an active
thrombokinase solution, coagulation occurs in less than
twenty seconds.
heat.

Thrombokinase is fairly resistant to

Even on boiling for several minutes, not all of

its activity is lost.

Oxidation, however, destroys its

potency, perhaps because of the presence of unsaturated
lipoids in its molecule (3,5).
It is widely accepted that cephalin is a constituent of the thrombokinase complex, but it is erroneous
to consider cephalin identical with thrombokinase (4,16).
(8)

Relatively little is known concerning the platelets as a source of thrombokinase.

Until recently it

was believed that they were derived solely from the
giant cells in the bone-marrow, but Howell and Donahue
(17) found that the platelets were also formed in the
lungs.

The resistance of these platelets plays an im-

portant part in releasing thrombokinase for the coagulation process, but this will be discussed more fully
under pathological physiology, and mentioned also under the role of calcium in the coagulation process.

Calci:!::!!:!!_:
For the conversion of prothrombin to thrombin, ionized calcium is essential.

Whether this element is pre~

sent in the thrombin molecule has not been decisively
answered, but it appears certain that the presence of
calcium is not needed for the action of thrombin on fibrinogen.

This is the original view of .Hammarsten which

recently has received strong support from the careful
research of Weitnauer and Wohlisch (1,3,4,18).
The normal values of serum calcium range between
9.6 mg. per 100 cc., and 10.8 mg. per 100 cc., of which

about 2 mg. per 100 cc. is in an ionized form.

This is

an indication of the relatively small amount of the ionized form needed in blood coagulation, and the ionized
(9)

form does not change noticeably even though the total
calcium be lowered to the level of tetany, about 4.5 mg.
per 100 cc. (19, 20,21,22).
But calcium plays two other very important roles
in blood coagulation: (1) in the lysis of platelets,
(2) in the function of the liver.
Earlier workers observed the preservation of platelets in decalcified blood.

Louc ks and Scott (23) felt

that this was due to the fact that calcium salt solutions lower surface tension.

Ferguson (24) proposed

the theory that "the surface tension lowering action of
a wettable surface is the primary cause of platelet alteration."

The change is one of osmotic imbibition and

partial plasmolysis in which the essential (specific)
role is played by calcium ions, making the platelets especially liable to osmotic influences.

It has been

seen by dark field examination that calcium salt solutions penetrate lipoid (lecithin) films, which suggests
the reason why water enters the platelets to cause swelling and lysis.
The reason for the blood remaining fluid in the
presence of - these factors is as yet unsolved, but Howell's
original theory of antithrombin factors and cephalin
availability is giving away now to the present concept
that the inception of coagulation is due to a disruption
(10)

"'

of the normal stabilized equilibrium of the entire col- .
loidal plasma complex, probably by the liberation of a
phospho-lipid fraction in some manner as yet not under
stood.
Musser (5) has recently shown that goose blood,
which will remain liquid for days, can be made to clot
in a few minutes on the addition of a small amount of
calcium chloride.

This finding also supports the cal-

cium factor in platelet lysis.
Many observers (25,26,27,28) have shown conclusive-

ly that calcium is necessary for the proper function of
the liver, and that function is improved in sub-normal
livers by the administration of calcium intravenously.
Calcium has also been proven to be of value in protecting the liver against damage, especially from chloroform
anesthesia and toxic bile salts in obstructive jaundice,
thus preserving the ability of the liver to manufacture
prothrombin, etc.

The exact mechanism of this action

in improving liver function has not been satisfactorily
explained, but there is no doubt that calcium does play
a very important part in liver function.
Probably the best explanat.ion of the deficiency of
calcium in the liver in certain conditions, even though
the blood level is normal, is that in rickets, calcium
is withdrawn from the bones at their expense in order

(11)

that the blood level may be maintained and thus prevent tetany.

If it is to be drawn from one organ (bone)

when there is a blood deficiency, why not from other
organs (liver).

Then in such cases, proper administra-

tion of calcium should not raise the blood level, but
allow the withdrawal of the amount needed for liver function without upsetting the balance in the blood.

Fibrinogen:
This substance is the passive factor in clotting.
This exceedingly labile plasma protein has the proper~y
of being converted from a colloidal solution or sol to
an insoluble gel by the action of thrombin.

In this

process, the fibrin forms fine needles or threads which
enmesh the cellular constituents of the blood.

Tocantins

(29) has shown that platelets will attach themselves to
the shaft of these fibrin threads, and in some inexplicable way cause these fibrin strands to bend and twist,
thereby effecting a compression of the fibrin mass, which
is grossly recognized as clot retraction.

Not only do

the platelets bring about the contraction of the clot,
but also in some obscure manner they increase the adhesiveness of the fibrin to the surfaces with which it
comes in contact.
is obvious.

The importance of this in hemostasis

The clot within the lumen of a severed

(12)

blood vessel by adhering tightly to the wall will bring
about by its contraction a mechanical constriction of
the blood vessel.
Fibrinogen occurs not only in the plasma, but also
in lymph, chyle, exudates and transudates.

Undoubtedly

this protein plays as i mportant a part in tissue repair
work as it does in coagulation.
The actual chemical reaction occurring when fibrinogen changes to fibrin is not known, but the original
view of Schmitt that it is proteolytic has recently
been convincingly supported by Eagle (discussed under
thrombokinase).

The concentration of fibrinogen in the

plasma may vary from 0.3 to over 1 ·percent, with an average of 0.2 to 0.4 percent.

It usually becomes elevated

in the presence of infection.

The coagulation time is

not perceptibly influenced by the concentration of fibrinogen, and clinically, a deficiency of fibrinogen as
a cause of bleeding is probably exceedingly rare.

The

liver appears to be concerned in the production of fibrinogen, arid in various types of hepatic damage a marked
decrease is often found, but normally, the body appears
to possess an enormous capacity to regenerate fibrinogen. (25-, 30)

(13)

Thrombin:
This substance is not a primary factor, but a resultant from the inter-reaction of prothrombin, calcium,
and thrombokinase.

Most investigators are accepting

the view that thrombin is an enzyme which acts specifically on fibrinogen.

An excellent summary of the evi-

dence for the hypothesis has been presented by Eagle
(12,31).

His demonstration that a preparation of throm-

bin coagulated over 2000 times its own weight of fibrinogen is difficult to explain on any other than an enzyme
basis.

Certain snake venoms such as that of the tiger

snake contain a substance similar or identical to thrombin, which is responsible for their powerful coagulant
action.

It must be remembered, however, that other

venoms lack the power to coagulate fibrinogen, but induce clotting by converting prothrombin to thrombin.
Recently Quick (11) has shown that thrombin is inactivated by serum albumin, and he has concluded that this
serum protein is the normal antithrombin of the blood
which is responsible for the rapid disappearance o_f
thrombic activity in fresh serum.

It should be noted

also that serum albumin does not inhibit the coagulation of fibrinogen, but acts only after the conversion
to fibrin has been complete.

(14)

Pathological Physiology
On the basis that prothrombin, thrombokinase,
calcium, and fibrinogen are essential for the clotting
of blood, and furthermore that coagulation may be inhibited by the presence of natural anticoagulants such
as heparin in the plasma, we must discuss the pathological physiology of each of these substance's deficiency in order to make a simple classification of hemorrhagic diseases.

Absence or marked deficiency of any

one of the primary factors gives rise to four potential
classes of bleeding diseases, and a fifth type arises
when a sudden liberation of heparin or a heparin-like
substance occurs into the blood stream.

An attempt will

be made to group the common hemorrhagic conditions into
these five classes.

Although prothrombin and thrombo-

kinase are treated as single substances, due cognizance
is given to the possibility that these agents may be
made up of several components.

If this be found the

classification would merely need to be enlarged, but not
fundamentally altered.

I. Diminished Prothrombin:

A. Deficienc1_ of Vitamin!•
a. Dietar1_ origin:
(15)

In 1934 Dam and Schonheyder (8) in Denmark, and
the next year Almquist and Stockstad (7) in this country demonstrated that a hemorrhagic disease could be
produced in chicks fed a d!$t comp l ete in all respects
except for a new unknown factor, which was fat soluble.
Dam named t his new substance Vitamin K.

Almquist found

that an ether extract of alfalfa had a hi gh concentration of t h is vitamin and readily cu red the bleeding
dyscrasia in chicks.

In 1936 Dam, and Tage-Hansen (32)

found that they could not isolate prothrombin from the
blood of chicks kept on a Vitamin K poor diet, and Quick
(10) a few months later showed that prothrombin began to
di minish four days after removing vitamin K from the diet
and could be reduced to less than 10% of normal in less
than three weeks.

He further found that prothrombin was

promptly restored to normal by addi ng 2% alfalfa meal
to the diet.

Kark and Lozner (33) doing a si milar ex-

periment on humans gave a known Vitamin K deficient diet
(no fruits or green vegetables) and decreased the prothrombin level in two to three days .

The prothrombin

level was restored i mmediately when put on Vitamin K,
but only slowly when just restored t o normal diet.

These

results definitely demonstrated that Vitamin K is necessary for the synthesis of prothrombin.
(16)

Recently Greaves (34) succeeded in developing a
hemorrhagic condition in rats solely by depriving them
of Vitamin K.

It is well known as the result of Alm-

quist's studies that Vitamin K is synthesized by the
bacteria in the intestinal tract, and this undoubtedly
explains the difficulty of producing a marked prothromboinemia by dietary means alone.

It is therefore doubt-

ful whether in the adult an inadequate diet by itself
can ever affect the prothrombin concentration seriously.
This propably explains why patients with peptic ulcers
can be kept on a continuous milk and cream diet for a
long period, without any serious decrease in prothrombin, and further tendency to increased bleeding from
the ulcer.
There is reason to believe, however, that the hemorrhagic diathesis of the newborn · may be caused purely
by a lack of Vitamin Kand the disease will be discussed
more fully.
The disease was recognized as far back as Biblical
days, as shown by the records of Mosaic law specifically
setting up the eighth day after birth as the time for
circumcision.

The disease as such was described in 1682

by Mauriceau and others, but their attempts to explain
it were meager, and it was not until a development of
the present concept of coagulation that any real progress

was made.
(17)

In 1921 Rodda made the interesting observation
that the coagulation time of babies bad a tendency to
increase after birth, reaching the maximum retardation
on the fifth day, but returning·" to normal before the
tenth day.

Lucas and his associates confirmed these

findings, but no satisfactory explanation could be given.
Gelatin solutions and whole blood injections were used
at this time. ( 35)
With the recognition of the importance of prothrombin deficiency as a cause of hemorrhage, and the discovery that Vitamin K is essential for the synthesis of this
clotting factor, came a new appro ach to the study of hemorrhagic disease of the newborn.

In 1935, Quick(53)

described a quantitative method for prothrombin and showed that this clotting agent was markedly diminished in
certain jaundiced patients, and especially in that of the
newborn.
Quick also showed that Vitamin K therapy cured the
disease immediately and could be used therapeutically.
These will be discussed more fully later in the paper.
The protbrombin level of the newborn is about 65-75%
of normal adult value.

On the first day after birth,

however, the prothrombin level drops and may reach very
low levels, then returning to normal after the fifth day
and being completely normal eight to ten days after birth.
(18)

The cause of the prothrombin deficiency seems to
be due to an inadequate storage of prothrombin or of
Vitamin Kin the fetus.

Presumably as soon as the baby

is born, the physiologic demands promptly exhaust the
available prothrombin.

Since there is apparently nei-

ther a reserve of Vitamin K nor of prothrombin, a marked decrease of the latter occurs.

The condition is

clearly due to a lack of Vitamin K, for not only can the
prothrombin be promptly res~ored by giving the baby a
concentrate of the vitamin, but also the serious fall
in concentration can be prevented by the oral administration of this food accessory substance.

Quick and

Grossman (35) have adequately proved this, and it was
further substantiated by Bohlender at the University of
Nebraska in 1940.
Since the drop in prothrombin is distinctly a manifestation of Vitamin K deficiency, the rise must be due
to · a suppay of this vitamin which was not present at
birth.

In view of the fact that the food intake during

the first few days is scarcely sufficient to assure an
adequate supply of Vitamin ·K, another source must be
sought.

As is well known, esp~cially from Almquist•s

work(?), bacteria readily synthesize Vitamin K.

At

birth, the intestinal contents of the baby are sterile,
but in a short time, especially if the baby is allowed
(19)

to suckle, bacteria are introduced, and an intestinal
flora is established.

The time relation between the

beginning of bacterial activity and the restoration of
the prothrombin level make it appear that the available
Vitamin K is of bacterial origin.

This explains the

rather puzzling finding of Javert (36) that the incidence
of hemorrhagic disease of the newborn in a large series
of cases was twice as high in the New York Hospital as
in the outdoor service of the Free Maternity Clinic.
The babies born under less sanitary conditions of the
home or tenement had a chance to infect their intestinal
tracts sooner than the babies born under the near ideal
conditions of the modern hospital.

Perhaps the practice

of putting the baby to breast early serves the primary
purpose of introducing harmless but useful bacteria into
the alimentary tract.
This condition is recognized by external or internal hemorrhage occurring during the first few days of
life; is C?aracterized by an exceedingly low prothrombin content of the blood; is usually self-limited, but
may be fatal.

It is probable that the disease may be

precipitated by a small hemorrhage, thus further reducing the depleted prothrombin as already discussed.
It is probable also that cerebral hemorrhage in babies
following delivery is one form of the hemorrhagic disease,
(20)

and that prothrombin is the important factor.

If the

latter clotting agent were normal in amount, the excess
of thrombokinase in the brain would speedily stop hemorrhage.
It must be recognized that other types of hemorrhagic diatheses may be encountered in babies.

Congen-

ital absence of fibrinogen, alth0ugh exceedingly rare,
can be the cause of bleeding.

Hemophilia, perhaps rare-

ly manifests itself immediately af t er birth, but must
be considered.

According to present concepts, a defi-

nite diagnosis can be made only by establishing a low
prothrombin by laboratory tests, or by curing the disease with Vitamin K.

If these two diagnostic tests are

negative when applied to an unknown bleeding condition,
it does not belong to the hemorrhagic disease of the
newborn classification as an entity.

Congenital fibrin-

ogenopenia and hemophilia mentione d above will be discussed under those headings later in the paper.

b. Faultz. absorption of Vitamin K:
It is well known that bile fistula dogs can develop
spontaneous hemorrhage.

Hawkins and Brinkhous found that

prothrombin was greatly diminished in these animals.

More

recently Greaves and Schmidt (34) showed that the prothrombin could be. markedly lowered by either ligation of
(21)

the bile duct or by making a biliary fistula.

The pro-

thrombin level in such rats could be readily elevated
either by massive doses of Vitamin Kor by feeding bile
salts.

The suggestion of Guick that the absence of bile

in the intestine leads to impaired absorption of Vitamin K with a resultant lowering of the plasma prothrombin is also the conclusion of subsequent workers.

Sur-

geons as far back as 1923 found that post-operative hemorrhage was less after feeding bile salts, but did not
know why.
It is highly improbable that a prothrombin deficiency can be produced in the adult by dietary means alone,
due to the synthesis of Vitamin K by intestinal bacteria
as discussed previously.

Thus far a reduction of pro-

thrombin has been observed only in certain intestinal
conditions in which absorption was impaired, and in biliary tract disease most commonly.

Quick, Stanley-Brown,

and Bancroft in 1935(37) reported that in certain cases
of jaundice, a severe diminution of prothrombin was found.
In 1938, these findings were substantiated by Brinkhous,
Smith and Warner, and by Snell and others of the Mayo
Clinic (28).

Both groups of investigators demonstrated

the efficacy of treating this deficiency condition with
Vitamin K and bile salts.

During 1'339 and 1940, many

others have added cases of biliary disease including
(22)

biliary fistuaa in which the hemorrhagic diathesis was
successfully treated with bile salts and concentrates
of Vitamin K.
Many other intestinal conditions may be present
which prevent the absorption of fat-soluble vitamins,
such as sprue, intestinal polyposis., chronic ulcerative
colitis, gastrocolic fistula, resection operations, and
prolonged intubation (38).
As has been stated previously, the bleeding tendency when Vitamin K is not absorbed, is due to the failure of the liver to synthesize prothrombin.

B. Liver Damage:
A tendency to bleed is a common occurrence where
there is severe liver damage.

This liver damage may be

traumatic, infectious, toxic, or due to anesthesia.

In

such cases the prothrombin is greatly diminished and
this of course accounts for the hemorrhagic tendency.
In acute yellow atrophy, a marked decrease in prothrombin was found, undoubtedly due to the inability of the
liver to synthesize it.

Recently Smith, warner and

Brinkhous (28) found that when a dog was subjected to
prolonged chloroform anesthesia, a marked drop in prothrombin occurred which was far more abrupt and severe
than the decrease in fibrinogen.
(23)

Quick (35) found in

chloroform poisoning that the prothrombin could easily
be reduced to five percent of normal.

Partial and com-

plete hepatectomy was done by Warren ~nd Rhoads, and
Warner (5), which showed the production of prothrombin
by the liver.

This proved conclusively that good liver

function is necessary to prevent hemorrhage, and suggested the possibility that surgical trauma and anesthesia might be responsible for some of the post-operative bleeding.
Lord (39) found that trauma to the liver, as is
necessary in biliary tract operations, causes profound
decrease in plasma prothrombin.

Since the majority of

jaundiced patients already have a decreased prothrombin
level, such a post-operative fall may easily depress the
prothrombin level to the bleeding point of 20%.
Cullen, Ziffren, Gibson, and Smith (40) found that
a number of patients with biliary tract obstruction had
only a slight decrease in prothrombin before operation,
but this decrease became marked after operation.

They

felt that this was due in a small part to the prothrombin lost by hemorrhage at operation, but mainlydle to
liver injury.

This liver injury was due to mechanical

trauma at operation, to the absorption of toxic by-products from the operative site, and to direct poisoning
of the liver by the anesthetic agent used.
(24)

They felt

that the effect of the anesthesia was the most serious
of the three causes, so they experimented clinically
and on animals to determine which anesthetics were the
least harmful to use.

Chloroform given py the closed

system with 50% oxygen, and no surgery performed, reduced the prothrombin level f~om 18% to 40%, within
24-48 hours after anesthesia was administered for onehalf hour.

All fully recovered in. three or four days.

By open drip method all cases showed a decrease of 56%
or more with a much longer period of recovery.

Ether

and cyclopropane were given over one to four~hour periods with no decrease in prothrombin (41 also).

There-

fore, it is unwise to use chloroform for biliary tract
operations.
Individuals suffering from severe hepatic damage
resulting from common duct stones or chronic cholecystitis or strictures of long standing, with the effect of
stasis of bile, and back pressure on liver cells, are
very likely to present a severe bleeding tendency preoperatively.

These patients often will not respond even

to large doses of concentrates containing Vitamin Kor
even to the synthetic compounds exhi biting antihemorrhagic activity.

In such cases, where the prothrombin

time does not respond to administrat ion of Vitamin K,
there is a distinctly added surgical risk.
(25)

It appears

that the ability of the liver to play some part ,in the
metabolism of prothrombin is one of the last functions
of the liver to be impaired, and thus indicates severe
liver damage and a poor operative risk.
The hepatic damage may be from a condition previously present as a hepatic cirrhosis from various conditions, and not ordinarily noticed before surgery on
some organ other than the biliary tract, where hepatic
function tests are not routinely run preoperatively.
The value of hepatic function tests as preoperative
diagnosis of bleeding tendency is of utmost importance
in all" biliary tract surgery and will be more fully discussed later.

C. Sweet Clover Disease:
Cattle which eat spoiled sweet clover hay often
develop a severe hemorrhagic disease which has considerable economic significance.

Frequently simple opera-

tions such as castrating bull calves, and dehorning cattle, are followed by uncontrollable hemorrhage.

Roderick

and Quick (42) determined that the prothrombin of the
blood was very seriously decreased, but on returning the
animals to a normal diet, the prothrombin level returns
to normal immediately and there is no evidence of serious organic damage.

It seems likely then that the toxic
(26)

principle found in this hay inactivates the prothrombin.

If this be correct, we must then recognize the

possibility that similar toxic agents may be encountered clinically which may attack the prothrombin of the
human blood.

There is no specific clinical condition

known today which has been proven such, but quite possibly some of the bacterial invasi ons do produce the
same picture.

II. Calcium Deficiencz:
. Although calcium plays a very i mportant part in
the coagulation mechanism, it has been difficult to show
any pathological physiological change which is responsible for a specific hemorrhagic diathesis.

Even with

parathyroprivia, where the calcium may reach the lowest
concentration compatible with life, no hemorrhagic diathesis has been shown to be associated.
much remains to be known.

Nevertheless,

The fact that administration

of calcium helps to restore impaired liver function in
cases of hepatic injury, particularly in jaundice, as
proven by Quick, Ravdin, Riegel and Morrison (25), and
the newly acquired knowledge of the importance of calcium in the lyeis of platelets, as explained in the previous discussion of calcium in blood coagulation, may lead
to new discoveries about the mechani sm of these functions,
(27)

which will permit the proper understanding of possible
calcium deficiencies, as they either directly or indirectly alter the coagulation process.

III. Thrombokinase Deficiencx:
Thrombokinase appears to be widely distributed in
the body as an intra-cellular substance, but only the
fraction locked up in the platelet seems to be responsible for bringing about dysfunction of the coagulation
process.

In order for blood to clot, free or available

thrombokinase is required.

If there is no contamina-

tion of tissue juices, the only source is the platelet.
An inadequate supply of thrombokinase obviously may
arise in three ways:
1. Reduction in the number of platelets.
2. Platelets deficient in thromboplastin.
3. Abnormal resistance of platelets to lysis.
It would seem that one can classify thrombocytopenia as a hemorrhagic disease on the basis of decreased
thrombokinase.

No doubt when prolonged coagulation in

this disease is encountered, it may well be the result
of thrombokinase deficiency.

Howell has studied a pat-

ient, who had a platelet count of 64,000 and also had
a prolonged coagulation time.

The platelet appears to

have another function, a specific effect on capillary
(28)

permeability, and in the purpuras this function far
overshadows the thrombokinase factor.

Vascular prob-

lems present too wide a field to include in a paper such
as this, however.
Apparently a marked reduction in platelets can occur without bringing about a delay in the clotting time.
A number of patients have been studied who may shift from
a condition of hemophilia with a normal number of platelets but a delayed coagulation time, to a purpuric syndrome with a marked thrombocytopenia but a normal clotting time.

Such cases have been described by Pickering

and by Minot and Lee (43).

The information concerning

the qualitative and quantitative variations of thrombokinase in the platelet is too conflicting and uncertain
to be of any specific value in differentiating and classifying hemorrhagic diseases.

The importance of abnor-

mal stability of platelets and the conflicting theory
of Eagle and Ferguson will be discussed under Hemophilia.

A. H~mo~hilia:
An adequate discussion of this subject would go
well beyond the confines of this paper.

An attempt will

be made merely to show how much of the evidence points
to the possibility that in hemophilia the platelets
(29)

are abnormally resistant and therefore yield thrombo- .
kinase too slowly to bring about coagulation within
the normal time, and also the evidence for the environment of the platelets being responsible for the failure to liberate th~ombokinase rapidly.
We will first discuss the findings that suggest
an inadequate quantity of thrombokinase.

In 1908

Morawitz and Lessen found that hemophilic blood clotted extraordinarily rapidly when an extract of kidney
tissue was added.

Kottman and Lidsky achieved the same

rapid clotting with a liver extract.

Schlossman and

Mills likewise demonstrated the effectiveness of tissue
extracts (4).

Since the tissue extracts of organs are

almost always badly contaminated with prothrombin or
thrombin, these earlier experiments were not entirely
satisfactory.

Quick, Stanley-Brown, and Bancroft (37)

succeeded in preparing a highly active preparation of
thrombokinase from rabbit brain, which was free from
prothrombin and thrombin.

On adding a measured amount

of this active material to hemophilic blood and to normal blood, both coagulated with equal rapidity.

From

these results Quick concluded: "This suggests that in
,,

Hemophilia the prothrombin is normal in quantity and
quality, but the thrombokinase is deficient."
(30)

Were prothrombin qualitatively altered, that is,
less reactive as Addis and more recently, Eagle have
postulated, one would expect that the action of thrombokinase would not be as effective on hemophilic blood
as on blood containing normal prothrombin.

Howe11(44)

in a recent comprehensive study on hemophilia has pointed out the probable error in the experimental studies ·
of Addis and Eagle on which their conclusion is based.
As the result of his latest studies, Howell concludes:
"As far as blood is concerned we may conclude that one
real difference between normal and hemophilic blood is
that the latter contains less thromboplastin in its
plasma.

There may be other differe~ces, but they have

not been discovered.

It would then seem permissible

to assume that this deficiency is sufficient to explain
the prolonged clotting time of hemophilia blood (also
46,47).
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Since Howell made this statement much import-

ant work has been done which has added to the information of cause of failure of hemophilia blood to clot.
This will be discussed in the next paragraphs.
Since thrombokinase takes on a new significance
in the consideration of the basic defect in hemophilia,
attention must be directed to the important source of
this clotting factor, namely to the platelet.

Since

the thrombokinaseLiS locked up in the platelet and be(31)

comes available only after the latter disintegrates,
the importance of the stability 0£ these cellular elements is obYious.

It seems, however, that rather than

the platelets being abnormally res i stant, the environment is the real determinant.

Howell (17) states that

when platelets are removed from their natural environ-

ment, freed from plasma, and suspended in saline solution, they become exceedingly resistant, and do not
break down when they come in contact with a foreigh surface.

Clearly this suggests that some factor in plasma

governs the resistance of the platelet in plasma, and
thus as a working hypothesis, one might suggest that
this labilizing influence is absent or depressed in hemophilia.

In support of this is the finding of Govaerts

and Grata (45) that platelets of hemophilic blood disintegrate normally in non-hemophilic plasma.

Fonia (45)

found that washed platelets, whether from normal or hemophilic blood, were more stable and to about the same degree.

More studies are required before one can defin-

itely state whether the abnormal stability of the platelet resides ' in the cell itself, or in tts environment,
but the latest studies are building up fatrly conclusive
evidence that the real cause of the failure of the platelets to release thrombokinase is the absence or depression of a labilizing influence of the plasma. More
(32)

knowledge of the function of albumin and globulin,
and other plasma factors must be acquired before the
actual factor responsible can be pointed out.
It seems justifiable, however, to classify hemophilia as a hemorrhagic disease caused by an insufficiently available supply of thrombokinase, and fill
in ther mechanism when known.

IV. Fibrinogen Deficiency:

A. Acquired Fibrinogenopenia:
As has been stated previously, it takes a very
small amount of fibrinogen for a clot to form, but there
is a critical concentration below which imperfect clot
formation occurs.

Risak states that there is a wide mar-

gin of safety, as he had a patient who had a level of
0.02% who showed no hemorrhagic tendency.

Normally,

however, 0.2% is considered the low range of normal (3,4).
Low fibrinogen may result from nutrition deficiency
(11).

Ham and Curtis have shown that this may occur in

pernicious anemia, scurvy and pellagra, thus confirming
earlier work by Starlinger and Winands.

A marked fib-

rinogenopenia may be sometimes found in myelogenous leukemia, myelogenic sarcoma, and other diseases involving
the blood forming organs.

Jurgens and Trautwine (5) re-

ported a patient whose blood was completely incoagulable

(33)

due to ·the absence of fibrinogen.

On autopsy, it was

found that the liver was normal, but a widespread destruction of bone marrow had occurred from a prostatic Qarcinoma.

Opitz and Silberman reported a similar case

caused by generalized tuberculosis.
Low fibrinogen values are found in severe liver
damage, especially in acute yellow atrophy.

It would

seem that the drastic reduction'" of prothrombin which
results from liver damage, as described previously, is
much more important as the cause of the hemorrhagic tendency, as this factor is altered earlier and more s·eriously.

Other causes of liver damage, particular.ly chloro-

form poison~ng, also lower the fibrinogen level, as shown
by Smith, Warner, and Brinkhous (28,35).

B. Congenital Fibrinogenopenia:
Consistent and complete absence of fibrinogen from
the blood due presumably to an inborn anabolic error has
been reported only three times.

Rabe and Soloman (48)

described the first case in 1921, Opitz and Frei (48)
the second in 1922, and in 1939 MacFarlane (48) presented a detailed case report of a third patient with congenital absence of fibrinogen.

The first and third were

over eight years old, indicating the importance of the
vascular defense mechanism a gainst hemorrhage, since in
(34)

neither case was there any evidence that the blood
was coagulable at any time in their life.

In the first

patient, the platelets were normal in number ·but appeared
resistant, the thttd patient had a thrombocytopenia up
to the age of eight.

MacFarlane believes that the de-

fect is inherited and has a recess i ve character.

Con-

sanguinity is believed to be a factor, as the parents
or grandparents of each of these cases were intermarried.
It is difficult to understand that in spite of the
complete incoagulability of the blood the two patients
that lived to be eight years of age es~aped serious incapacitation hemorrhages, such as bleeding into joints,
as is usually true in severe hemophilia.
The differential diagnosis between true hemophilia
and fibrinogenopenia can be made by the simple addition
of a few drops of thromboplastin solution to the blood.
Hemophilia blood clots promptly, but no effect is seen
on the second blood.

V. Anticoa~lants:
The presence in the blood of any agent which neutralizes or inactivates one of the four factors required
for coagulation can hypothetically bring about a hemorrhagic state.

The antithrombins and possibly antipro-

thrombins are the only ones that need to be considered
(35)

clinically.

There is no evidence that the blood ever

contains any substance which renders fibrinogen incoagulable, or neutralizes thromboplastin.

Also, the agents

which prevent clotting by removing ioniz ed calcium, sucp
as the soluble oxalates and citrates, although very valuable for in vitro experiments, are not encountered clinically as causes of hemorrhage.

Except for the use of

sodium citrate in transfusion, no extensive use of these
reagents to inhibit coagulation is made at present.
In considering antithrombins, it is important to
recognize that blood contains a natural neutralizing
agent of thrombin, which Quick (49) has shown to be
either serum albumin itself or a substance closely associated with it.

Both fibrinogen and albumin have an af-

finity for thrombin but the former is greater.

The . ac-

tion of thrombin on fibrinogen has been discussed previously, and as soon as fibrin is formed thrombin is reliberated to react with more fibrinogen, and only when
coagulation is complete does the albumin get a chance to
combine and thereby neutralize thrombin.

Quick has shown

that heparin acts by intensifying the antithrombin activity of serum albumin.

By adding heparin to the blood,

a strong anticoagulant , presumably an albumin-heparin
complex is formed, which combines with thrombin before
the latter can react with fibrinogen.
(36)

It is thought

that this complex combines with prothrombin also,
preventing the formation of thrombin.

His work has

been confirmed by Brinkhous, Smith, Warner, and Seegers
(13).

It is unlikely that heparin i _s present in normal
blood.

Quick has developed a titration method for de-

tecting heparin in plasma, which is sensitive to less
than 1 mg. of heparin per 100 cc. of blood • . He was
unable to: find any trace of heparin in normal plasma.
There is, however, good evidence that heparin appears
in the blood both in peptone and anaphylactic shock.
Howell attributed the incoagulability of the blood in
peptone shock to heparin. · Quick, Eagle, Johnston, Ravdin,
Pepper, Krumbharr, and La Barre all have confirmed the
presence of heparin in peptone and anapbylactic shock,
and all came to the conclusion th A.t the delayed coagulabi li ty was due to its presence.
Recently, Waters, Markowitz and Jaques (50), employing the finding of Chargaff and Olson (51) that prota mine sulfate completely re mo ves heparin from blood, were
able to determine quantitatively the heparin in the blood
after both peptone and anaphylactic shock.

They further

found that no antithrombin occurred in a shocked liverless dog, and concluded that this organ was responsible
for the outpouring of heparin.
(37)

Many other substances are known which can inhibit
the activity of thrombin.

Of these, ceTtain sulphur

compounds such as cysteine, methionine, taurine, and
taurocholic acid, have been shown by Sterner and Medea
(52) to act as anti-coagulants.

It seems questionable

whether these sulphur compounds or any other anti-coagulants, except heparin, need to be considered as 1causes
of hemorrhagic conditions seen clinically.

(38)

CLASSIFICATION OF HEMORRHAGIC DISEASES
CAUSED BY DEFECTS IN THE COAGULATION MECHANISM
I. Diminished prothro mbin (Prothrombinopenia)
A. Lack of Vitamin K:
a. Dietarz. origin:--absence of bacteria in intestine;
1. Hemorrhagic disease of the newborn.
b. Faultz. absorption:
1. Obstructive Jaundice.
3. Biliary Fistula.
3. Chronic ulcerative Colitis.
4. Intestinal Polyposis.
5. Gastrocolic fistula.
6. Resection Operations.
7. Short-circuiting Operations.
8. Prolonged Intubation.
9. Sprue.
B. Liver Dama~:--faulty utilization of Vitamin K:
a. Anesthesia (only chloroform at present)
b. Surgical Trauma.
c. Prolonged obstruction of bile ducts.
d. Acute Yellow Atrophy.
e. Hepatitis.

f. Cirrhosis.
g. Malignant Growth in L1ver.
h. Partial Hepatectomy.
(39)

•

Classification continued:
C. Toxins:
a. Toxic sweet clover disease of cattle.
b. Similar unclassified conditions in man.
II. Calcium Deficiencz:
(No specific clinical hemorrhagic condition known
which is entirely attributable to calcium lack,
but calcium therapy valuable in improving liver
function, especially from chloroform anesthesia,
and toxic bile salts in obstructive jaundice, and
also in preventing such damage.)
III. Deficiencx_ of 'rJ).l,"_Ql!IQOlciI1af3_e:
A. Diminished number of Paatelets:
a. Thrombocytopenia--(this is better classified
under defective vascular res ponse, since the
effect on capillary permeability is much
greater than the deficiency in thrombokinase.)
B. Decreased Platelet Lisi~:
a. Hemophilia.
C. Deficiencx_ of Platelets in Thrombokinase:
(No specific disease classiiied here yet)
IV.

Deficiency of Fibrinogen: (Fibrinogenopenia)
A. Acquired Fibrinogenopenia:
a. Nutritional deficiencies.
b. Diseases of the blood for ming organs.
1. Myelogenous Leukemia.
2. Myelogenic Sarcoma.
3. Generalized Ca rcinomatosis.
c. Severe liver damage.
(40)

Classification Continued:
B. Congenital fibrinogenopenia.
V.

Anticoagulants in the blood:
A. Liberation of Heparin into Blood.
a. Anaphylactic shock.
b. Peptone shock.

(This classification does not include hemorrhagic conditions due to defective vascular response) .

(41)

Prediction of Hemorrhag!_Q_ Tendency
If we are to p r event hemorrhage by rational preoperative administration of substances, we must have
a method of predicting a hemorrhagi c tendency and identifying the deficient factor.

Havi ng set up the ac-

cepted mechanism of normal clotting, and explaining
what happens in abnormal conditions, it is now necessary to ou tline a scientific approach to the problem
of diagnosis of a deficiency in the blood coagulation
mechanism.
The blood clotting ti me (coagulation time) is essential but not conclusive for determining the hemorrhagic tendency of a patient.

The clotting time may be

normal though spontaneous bleeding be present, that is,
in purpuras and jaundice, and clotting may be delayed
although there be no hemorrhage.

A prolonged coagula-

·,·

tion time may be due to diminished prothrombin, thrombokinase, or the presence in the blood of an anticoag~
ulant such as heparin.

If the blood ul ti ma t·e1y clots,

the presence of fibrinogen is established, but a qualitative method of determination wi l l be given later.
The determination of the clotting time of blood
passing through skin is no criteri on of the true clotting status of the blood and hence no indication of
what might be expected in the operative field of 6ther
(42)

tissue.

All injured tissues, as well as blood when

shed, dissociates into substances conducive to their
coagulation.

This contributory tissue factor m~y be

eliminated by taking the clotting time by vein puncture.

Although the skin puncture method is most com-

monly used clinically, the vein puncture method should
be encouraged.
Clotting time (Vein Puncture):

Draw one cubic

centimeter of blood and transfer to a test tube eight
millimeters in diameter.
at 38°0.

Place the tube in a water bath

Coagulation is complete when the tube can be

inverted without displacing the clot. (Normal, five to
eight minutes). (55,56).
Clotting time (Skin Puncture):

Touch the end of

a capillary tube (3 cm. x 0.6 cm.) to the first drop of
blood issuing from a stab in the finger or ear.

Place

in the creases of the palm and cover by closing the hand
to maintain a fairly uniform temperature (34o_35oc.).
The clot formation time is the time needed until the first
fibrin thread is seen between the ends when the capillary tube is broken by bits every fifteen seconds. (Normal, three to five minutes). (55).
A deficienc~ in prothrombin is readily determined

by either quantitative measurements or by determining
the prothrombin time and comparing i t with normal blood.

(43)

Wright's method is the most scientific, although the
Quick and Mill's modifications are good simple bedside
tests.
Wright's method of Prothrombin Time and Index:
Blood obtained by skin puncture is drawn into a Wright
tube containing 0.1 cc of 1% sodium oxalate and centrifuged.

One-tenth cc. of the plasma is placed in three

tubes (6.8 x 1.3 cm.) and flat-bot t omed) in a water bath
at 38°0., and to these are added in series 0.1, 0.2, and

0.3 cc. of 0.5i CaC1 2 .sH2o.

The shortest clotting time

in the series is the prothrombin time.

The £rothrombin

index is the rat io of the clotting of the control to that
of the patient's blood.

(Normal is J.D).

Quick's test of Prothrombin ti me:

A drop of blood

from heel or ear lobe puncture is put on a glass slide,
and mixed with a drop of equal size of thrombokinase.
The mixture is slowly stirred with a fine-pointed stirring rod.

By holding the glass slide over a light, the

exact clotting time can readily be determined.

(Normal,

fifteen to twenty seconds).(53).
Mill's modification is run si milar to Quick's test,
with the calculation of the ratio of normal blood to
patient's blood expressed in percent as the reading.
Nor mal for his' method is 26 seconds, .and 1001, is normal.
Any reading below 401, is definitely dangerous for hem-

(44)

0rrhage, and any reading below 70% demands therapy. (54).
Although fibrinogen is rarely deficient, we nmst
outline a method of determining quantitatively this deficiency to be used when the other more common factors
prove norma~ and there is still a bleeding tendency.
Fibrinogep. ya}-11~:

Blood is drawn into a tube con-

tai ning 0.2 cc. of 3.5i sodium citrate and centrifuged
under albolene.

The refractive index of one drop of the

plasma at 38 C. is estimated by means of a Pulfrich refractometer.

One-tenth cc. of

1.5%CaC1 2 .sH2o

is added

to the tube to coagulate the fibrinogen, and is then
centrifuged.

The refractive index of a drop of the seru~

is then determined.

The percentage of the blood fibrin-

ogen is the difference between the indices of the plasma
and serum multiplied by the factor 0.187.
0.3 to 0.6~). (55).

{Normal is

Todd and Sanford also give a method

which might prove somewhat more simple.
Determination of Platelets:

(This is necessary to

rule out the thrombocytopenic purpuras).

Draw blood with

a red blood counting pipette and dilute with 3%' citrate
(1:200) without adding any stain as a diluting agent.

All ow the -cell to stand for ten minutes before counting
the platelets in the customary counting chamber. (55).
{Normal, 200,000).
(45)

Platelet Lysis Percentage: (This is very important
as only the lysed platelets function in coagulation, and
of course a low percentage of lysed platelets indicates
hemophilia).

Blood is collected in a short paraffined

tube and platelet counts are made at fifteen-minute intervals, counting only those which are single and not agglutinated into clumps.

The platelet lysis percentage

is the fraction of the platelets which disintegrates within one hour. (55).
Antithrombin is also one of the rarer causesof defective blood coagulation, but again we need a method of
determining whether or not it is increased.
Antithrombin index determination:

Blood obtained

by skin puncture is drawn into a Wright tube, allowed
to clot, and then centrifuged. -0.1 cc. of serum is drawn
off into a small test tube by means of a capillary pipette
and heated in a water bath at 6€)0 0. for ten minutes.
(Prothrombin is thus destroyed).

A control blood is

carried through the same procedure.

The heated serums

are cooled and to each is added 0.3 cc. of prepared thrombin solution.

The tubes are placed in a water bath at

38°0. for fifteen minutes.

0.5 cc. prepared fibrinogen

solution is finally added to each tube and the clotting
time is observed at 38°0.

The antithrombin index is the

ratio of the clotting time of the patient's blood to that
(46)

to that of the control.

Details for the preparation

of fibrinogen and thrombin can be found in any lab manual.

(Normal index is 1.0). (55).

Since calcium, fibrinogen and antithrombin are
rarely responsible for demonst~able change in the coagulation process, and only prothrombin and thrombokinase
remain as the important factors in bringing about disturbances in the clottingof blood, we must determine
just which of the above tests need b~ run preoperatively
as a routine procedure.
Bancroft, Kugelmass, and Stanley-Brown (55) have
worked out a rather simple method by which they determine the blood clotting index on ail surgical patients
preoperatively.

Since prothrombin, fibrinogen, and plate-

lets tend to favor clotting, and antithrombin te~ds to
reverse the process, then in this chemi cal mechanism the
activity for clotting or bleeding is proportional to the
concentration of each interactive substance.
Prothrombin + Fibrinogen+ Platelets~ Anti thrombin
(Active)
Expressing this reaction in the terms of mass action,
(Prothrombin) (Fibrinogen)

(Active Platelets)

(Antithrombin)
(47)

=1

Introducing the normals for these substances, we get,
the normal index of clotting function of-blood, which
is 0.5 ± 0.2.

Values over 1.0 indicate a marked tendency

to blot and values below 0.2 indicate a marked tendency
to bleed.
They have used this method routinely for several
years and have decided that it is a true indication of
the clotting ability of the blood.

Whether or not this

method should be accepted generally is debatable, but the
determination of the following factors can be made in one
hour and surely the measurement of these factors would
give a measurement of the necessary substances for r clotting, and treatment could be aimed at the deficient factor.
1. Bleeding time.
2. Clotting time.
3. Prothrombin index.
4. Antithrombin index.
5. Platelet Count.
6. Degree of platelet disinte gration.
If the prothrombin time be proven low, liver function tests, (57,58), such as the hippuric acid test,
should always be made to determine the extent ofliver
damage.

This will allow therapy to be aimed both at
(48)

raising the prothrombin level by Vitamin K therapy if
indicated, and also at improving the liver function,
if not damaged beyond repair.
Since serum calcium levels do not help in diagnosing coagulation defects, it is a waste of time to
determine them, even though we know therapy is indicated in certain conditions mentioned previously, as in
liver damage in obstructive jaundice.
If there is a : hemorrhagic tendency due to defective coagulation mechanism, the above tests will certainly show the cause, and if no abnormality is found,
then the hemorrhagic disease must be considered from
the vascular point of view.

The Duke bleeding time,

the capillary resistance test of Rumpel-Leede or Hess,
and the clot retraction time are positive only in diseases, such as the purpuras, where the fundamental defect is vascular.

(49)

✓
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Evaluation of Anti-Hemorrhagic Substances
There are many commercial preparations available
which are labelled

1

hemostatics 1 a nd which have been

widely used in a desperate attempt to stop bleeding.
Some of these are of definite value where the deficiency is known, and some are worthless regardless of
the cause of hemorrhage.

Since we have set up an in-

telli gent approach to the identification of the deficinet factor, it seems wise to group the antihemorrhagic
substances according to deficiency ·which they attempt
to restore to normal, and discuss t hose 'shotgun' hemostatics later.

Prothrombin Deficiencz:
The physiology of a protbrombin deficiency bas
been discussed previously, namely, f rom the failure to
absorb Vitamin K from the intestine , orfrom the inability of the liver to utilize it in the synthesis of prothrombin.

Therefore, the ai m of treatment must neces-

sarily be to increase absorption of Vitamin K from the
intestine if possible, or if not, t o administer it hypodermically or intravenously, and to i mprove the function of the liver, so prothrombin may be formed.

As Quick and others have shown (See hemorrhagic
disease of the newborn), the dietary lack of Vitamin K
(50)

is entirely responsible for the diminished prothrombin in hemorrhagic disease of the newborn.

Since it

is conceded that the prothrombin is sufficient at
birth, the prevention of the fall in its level is the
important problem.

Waddell and Querry. as well as

Quick (35), have demonstrated that this can be readily accomplished by administrating Vitamin K orally.
In a normal infant, this is hardly necessary, as a
return to early breast feeding will be sufficient.
But in any case of difficult labor in which intracranial injury is likely to occur, the oral administration
of aconcentrate of Vitamin K should be begun and be
continued for seven days.

Vitamin K should also be

given promptly if slight oozing is noticed fromnthe
umbilical cord or any other small wound, or if blood
appears in the stool or urine.

Unless the hemorrhage

is severe, a direct blood transfusion need not be
given since Vitamin K acts very promptly and will restore the level within 6-12 hours.

If it is necessary

to operate on a child before it is one week old, the
prothrombin level should be determined, and if found
low, Vitamin K should be given preoperatively.

One

or two milligrams daily is a sufficient dose.

This

is a specific antihemorrhagic agent in this case and
gives immediate curative effects, and is very effect(51)

--as a therapeutic measure (also 59).
Where the diminished prothrombin is due to a
lack of absorption of Vitamin K, as determined by the
usual methods of diagnosing biliary tract obstruction
and lack of bile salts in the intestine, the oral administration of Vitamin K together with bile salts immediately restores the prothrombin to normal, so normal
clotting can occur and operative procedures on the biliary tract can be accomplished safely without excessive
bleeding.
H. R. Butt (60) outlined the treatment of such
cases at the Mayo Clinic.

They divide their patients

with jaundice into three groups for the purpose of routine preoperative therapy: 1, those in which the prothrombin time is normal; 2, those in which the prothrombin clotting time is prolonged but active bleeding has
not occurred; and 3, those in which prothrombin clotting time is prolonged and active bleeding occurs.
If prothrombin time is normal , prophylactic treatment is administered for from two to five days before
surgical intervention is undertaken, in order to prevent a low level resulting from the surgical trauma.
From 2 to 6 gelatin capsules (each containing approximately 200 mg. of alfalfa concentrate) together with
from l to 4 gm. of animal bile salts, constitute an
(52)

adequate daily dose.

Any type of animal bile salts

cah be used, but water-soluble salts are preferred,
especially where concentrates of Vitamin K must be
administered by means of a duodenal or T-tube.

Human

'

bile obtained from a biliary fistula or T-tube also
may be used.
If the prothrombin time is elevated and jaundice
is present, this constitutes a potential or real emergency • . Most patients who have a prothrombin time of
30-45 seconds will respond well to the prophylactic
treatment mentioned above, but if the prothrombin time
is more than 45-50 seconds, it is advisable to administer concentrates of Vitamin K together witp bile salts
either by a duodenal or T-tube.

In such instances,

from 2-4 gm. of a water-soluble bile salt is dissolved
in from 250-500 cc. of warm physiologic solution of
sodium chloride or tap water; to this is added from
1 to 2 gm. of the concentrate of alfalfa containing
Vitamin K.

The mixture is shaken th@roughly and adlh~n-

istered slowly in from 30-60 minutes by the drip method.
One such dose, as a rule, will bring the prothrombin
clotting time to a normal value.

It has in exception-

al cases been necessary to repeat the procedure, and
when lar~e or repeated doses are used, the prothrombin time usually decreases within 6-12 hours.
(53)

If the prothrombin time is elevated and actual
bleeding is present, it is necessary to remove clotted
blood by lavage before adequate.absorption can occur,
and not infrequently gastric lavage and irrigation of
drainage tubes leading from biliary tract are required.
Transfusion of blood is often necessary to combat shock
produced by hemorrhage and to provide a temporary supply of prothrombin.

As a rule transfusion will control

bleeding only as long as the additional supply of prothrombin lasts, that is, from 6-12 hours.
The prothrombin time of patients who have jaundice usually increases to some extent for the first
three or four days after surgical operation~ but it
may increase rapidly even as late as the eighteenth
post-operative day.

For this reason, the prothrombin

time should be d.e termined daily for the first four days
after operation, and then every other day for at least
8 or 10 days longer, and any increase in the prothrombin time should be considered an indication for the
immediate administration of a concentrate of Vitamin K
and bile salts by mouth or duodenal tube.

To those

patients whose prothrombin time before surgical treatment bas been high, it is wise to administer the vita~
min and bile salts daily for several days after surgical operation, regardless of the prothrombin clotting
(54)

time.

A patient who has a prothrombin time of more

than 30 seconds should be prepared with particular
care and one who has a prothrombin time of more than
45 seconds, must be considered a potential bleeder and
treated as such (also 62,67).
It has been learned that a normal prothrombin
clotting time on the day of operation does not guanantee the non-occurrence of post-operative bleeding and
the close attention to the risk of hemorrhages is warranted in the treatment of all patients who have obstructive jaundice and hepatic damage arising from any cause
whatsoever.

This statement applies particularly to

that group of cases of acute, subacute or chronic cholecystitis which come to operation.

A large number of

these patients do not have any jaundice on admission
to the hospital and prothrombin time is usually within
normal limits.

However, at operation these patients

not infrequently are found to have marked hepatic damage which is recognized on gross examination by the
surgeon.

In this group of cases danger of bleeding is

real and the prothrombin clotting time must be watched
closely to prevent late post-operative bleeding.
The importance of the integrity of the liver in
the hemorrhagic diathesis associated with deficiency of
proth:rombin has been menti oned already.
(55)

If hypo-Pro-

thrombin is accepted as the factor principally responsible for t he hemorrhagic tendency of a patient who has
jaundice, in many instances the element of damage to
the hepatic parenchyma may be assumed to have a fistinct bearing on the condition.

Patients have been ob-

served who presented every known clinical evidence of
hepatic insufficiency and who exhi b ited maxi mal physio-

_.,-'

logicic disturbances (as determined by studies of hepatic function), yet these patients have been able to
utilize Vitamin Kand to maintain normal concentration
of prothrombin in the circulating b lood.

Patients

have also been seen, however, who have had certain severe hepatic damage and who did not present the usual
prompt response in prothrombin clotting time after administration of Vitamin K.
Individuals suffering from severe hepatic damage
resulting fro m common duct stones or chronic cholecystitis or strictures of long standing are likely to present this type of clinical picture.

These patients

often will not respond even to large doses of concentrates containing Vitamin Kor even to the synthetic
compounds exhibiting antihemorrhagic activity.

In cases

in which the prothrombin clotting ti me does not respond
to the administration of Vitamin K, there is a distinctly added surgical risk.

However it appears that the
(56)

ability of the liver to from prothrombin is one of the
last functions i mpaired.
In those intestinal conditions where the surface
is not adequate and physiologically intact (described
previously), proper absorption of the fat-soluble material cannot take place, and of course the Vitamin K
deficiency and low prothrombin level will result. In
these cases, one of the synthetic Vitamin K preparations must be given intravenously until the intestinal
condition can be cleared up medically if possible, and
surely adequate intravenous Vitamin K therapy must be
given before any surgical treatment such as a resection
be attempted.

Dixon and Gregg (61) at Mayo's have been

able to stop severe rectal bleeding from polyposis and
ulcerative colitis by the use of Vitamin K.
When hepatic injury is proven in cases of jaundice,
as mentioned above, as determined by hippuric acid test,
~

calcium salt, preferably gluconate, and glucose

solutions should be administered pre-operatively for
several days in order to improve the liver function.
Quick (20), Ravdin, Rie gel and Morrison (25), have verified the importance of these factors.

Vitamin K !2.!.fil2.arations available:

The na.t ural

sources of Vitamin Kare alfalfa, spinach, and putre(57)

fied fish meal, and from these sources crude concen-

-,

trates have been made which are high in potency and
give very satisfactory results on oral administration
or by T-tube.

These are available in gelatin capsules

of 200 mg. each, or may be purcha.sed in a sterile rubber-stoppered vial.

They are not pure enough for in-

travenous use. (60,68,69,70).
Several synthetic compounds are commercially available, the most effective of which is 2-methyl, 1,4-;naphthoquinone .

It is available in 1,2,3, and 5 mg. tablets

for oral use and also as a sterile powder which can be
mixed with sterile saline and used intravenously.

The

dose of this preparation is 1 or 2 mg. with 5-10 gr.
of bile salts per day orally, or 1 mg. in NaCl for intravenous use.

2-methyl, 3-phytyl, 1,4-naphthoquinone

is another synthetic compound which is about equally
active.
These preparations have been given trade names by
the various pharmaceutical houses which prepare them,
and can be identified by the names Klotogen, Ceraphyl,
Phtyiocol, or Vitamin K, and no toxic effects have been
demonstrated for any of these substances which are commercially available (60,70-74).
It is important to remember that regardless of the
source of the Vitamin K employed, the basic essentials
(58)

for handling a case of hemorrhagic diathesis resulting
from prothrombin deficiency remain the same.

The pro-

thrombin clotting time must be watched carefully and
the physiologic principles which underlie the syndrome
present must be kept in mind.

Calcium DeficiencI:
As has been discussed previously, no clinical hemorrhagic diathesis as an entity is known which is due
to a decreased blood calcium level, so we must assume
that the deficiency of calcium is expressed in an indirect manner, as in its action on the liver previously
discussed.
Calcium

J2I:

mouth has been advocated since 1893

by (Wright) for the control of hemorrhages and the acceleration of the coagulation process.

In spite of the

negative observations made under reliable conditions
by Addis, Dale and Laidlaw (75), and Loewenstein (20),
and Politzer, reports appear from time to time of the
effective action of calcium when taken by mouth, and
these writers advocate the use of calcium by mouth preoperatively to diminish bleeding.

Positive results

from oral administration are shown by Colemann, Hinman,
and Sladen (76).

More recent advice to use calcium

chloride or calcium lactate in this way is given by
(59)

Thibault and Fitzgerald (76).

The r e is some evidence

that calcium gluconate is better absorbed than either
of the other two salts, and therefore has a better
prospect of being effective orally.

Further evidence

that i mproved absorption of calcium might be desirable
is seen in the results of Matusevich, who has found that
the addition of ammonium chloride, which is known tto
increase the absorption of calcium, shortened the coagulation time more than addition of calcium chloride alone.
His results may be taken as reliable as he used adequate
control of conditions and standard statistical methods
of determining and evaluating resul ts.
Tainter a nd Throndson (77) gave calcium gluconate
for fro m fourteen to twenty days, i n a dosage of 13.5 gm.
a day, taken in the form of chocol a te-coated tablets,
with each meal, and maintaining absolutely constant conditions, maintaining a constant relationship to meals ·
and to other activities, and having a two-week control
period both before and after the period of administration
of the drug.

They determined thei r results by the ac-

cepted standard statistical method , by which the Critical ratio was determined.

A critical ratio of 2.0 gives

a probability of 20 to 1 that the result is not due to
chance, and that the result is val i d.

With the admin-

istration of calcium gluconate by this method, they got
(60)

a decrease in coagulation time, but it did not meet
their standard of a critical ratio of 2.0, so they say
the decrease is not significant, and cannot be relied
upon to reduce coagulation time significantly.

In view of the fact that Matusevich observed a
shortening of coagulation time with calcium when absorption was increased by the use of ammonium chloride,
an attempt was made to obtain the same results by a
more normal means of increasing calcium absorption, that
is, :!2.l_ the administration of Vitamin D.

It is now well

established that Vitamin D largely controls the normal
calcium absorption from the gastrointestinal tract, and
that administration of increased amounts of this vitamin brings about an increase in calcium absorption. Apparentl~ the application of this fact to shortening of
coagulation time clinically has received little attention, as there is little written on the subject clinically.

Seyle, in 1928, gave massive, and probably

toxic doses of irradiated ergosterol to rats and observed a decrease in the coagulation time.

Similar obser-

vations were made by Phillips, Robertson, Carson, and
Irwin in 1931. (78).

The only similar clinical report

seen in the literature is that of Brougher, who, in 1930,
reported that administration of Cod Liver Oil or Viosterol in therapeutic doses reduced the coagulation time
( 61)

by from one-half to two-thirds.

However, in his ex-

periments, there was only a single control observation on each subject before medication, and this lack
of adequate control leaves the validity of the observations in question.
Tainter and Throndson (77), using the same standa rd control conditions described above, gave calcium
gluconate in dosage of 13.5 gm., with a daily dose of
one cc of ciosterol, which bas a vitamin D potency of
10,000 U.S.P. units per gram, their patients receiving
about three ti mes the usual maxi mum therapeutic dose.
Their results for the , group gave a critical ratio of
over 2.0 so there was little chance that the decreases
in average coagulation ti mes observed we re due to chance
fluctuations.

However, in about one-half of their ser-

ies, the coagulation time was mark edly reduced, so that
they concluded tha t massive doses of calcium and viosterol together may decrease the coagulation time in
about one-half the patients.

Although it is generally

recognized that alterations in the amount of ~vailable
calcium in the blood are produced only with great difficulty, the results obtained under such accurate experimentation cannot be ignored.
There is considerable evidence that injection of
calcium salt solutions intravenouslz can shorten the
(62)

coagulation time materially, as proven by Crane and
Sanford (21), Cowar and Wright (26), and Quick (30),
and others (25,79), but there is no conditio"n where the
need of calcium is so immediate as to make this necess a ry or practicable.
We must certainly conclude 1t·rom this experimental work, and the various clinical reports, that there
are cert~in conditions in which the administration of
calcium is of definite value in shortening coagulation
time, but we certainly should not advocate its routine
use as an antihemorrhagic substance.

At the present

time, we can say that in cases of jaundice, and in other
conditions where liver function is sub-normal, the administration of calcium is of defi nite value, and that
the best means of administrati on is to give calcium
gluconate, together with adequate doses of Vitamin D,
by mouth.

Until the physiology of calcium in other con-

ditions is more fully worked out, we can go no further.

Deficienc~ of Thrombokinase:
Providing th at thrombokinase i s the only deficient
factor and it usually occurs singly, the addition ·of
a thrombokinase preparation will definitely s horten the
coagulation time· and restore it to normal.

The action,

as discussed previously, is to rapidly convert pro(63)

thrombin to thrombin.

When all of the prothrombin

has been converted to thrombin, the further addition
of thrombokinase will not shorten the coagulation time.

As explained in the pathological physiology, the
deficiency of thrombokinase may be due either to decreased number of platelets, or to a decreased lysis
of platelets.

Therefore, the aim of curative therapy

would necessarily have to be directed at these factors.
The administration of thrombokinase preparations then
is not curative but definitely of value as a temporary
measure to control bleeding due to thrombokinase deficiency in the blood, but until more is known about
the mechanism of platelet lysis, curative therapy cannot be administered, and we must be satisfied with effective temporary treatment.
Where the number of platelets is low, many attempts
have been made to increase them by the administration
of CongQ_ Red.

Experimentally an increased number of

platelets is found in the blood following the injection
of this dye.

This has been proved by Graves and Kic~ham

(80), and by Quick (4) and others.

The action is ex-

plained as a stimulus to the reticule-endothelial system,
which results in increased formation of platelets.

Clin-

ically, the injection of Congo Red in doses of 5 or 10 cc.
intravenously has both increased the number of platelets
(64)

and shortened the coagulation time where this factor
was proven deficient, but the negative results resulting from its indiscriminate use in bleeding regardless
of cause has given it a poor name and it is generally
considered as a worthless hemostatic.

Its use can be

recommended, however, where platelet count is low,
and this is t he only deficient factor.

Thrombokinase 12.!:fil2arations:
Most of the thrombokinase substances which are commercially available are prepared from bovine brain tissue.

Those for local or oral use consist of tissue

fluids containing finely ground particles suspended in
physiologic saline.

The solutions for hypodermic ad-

ministration are made by dilution, after removal of
coagulated proteins and particulate matter, or the material used in the preparation of the local or oral product.

The oral use has not proven effective, so we

will limit out information to the intravenous and intramuscular preparations.

It has been shown by Aggeler

and Lucia (76), that the potency varies with the species from which t he brain is taken, and that in order
of potency are horse, dog, calf, rabbit, sheep, and
guinea pig, with sheep and guinea pig being very in-

effective.
(65)

The available brain tissue preparations are:
1. Thromboplastin (Armour). given intramuscularly, in doses of 1 cc. for each 75 pounds of
body weight daily.
2. Thromboplastin (Lederle), given intravenously, in doses of three to five cc. every 24-48
hours.
3. Thromboplastin (Squibb), given intravenously in doses of 10-20 cc. every 24-48 hours.
Aggeler and Lucia (76), and Pickering and Hemingway (81), in a comparative study of these preparations,
found that all were very effective, but Lederle's was
the most efficacious.
Coagulen (Ciba) is a thrombokinase preparation
made from blood platelets, and is to be administered
intravenously in dosage of 10-20 cc. of a 3% solution~
This was proved by the above workers to be effective,
but not so much so as the brain tissue preparations.
Bussacca (106) uses 20 cc. sub-cutaneously preoperatively and claims excellent results.
Fibrogen (Merrell)is a lung extract, the active
agent being thrombokinase.

It is £or oral use in 10-30

cc. doses, but did not produce sufficient change to be
considered valuable.

Other workers have determined

oral administration of these preparations to be effective,
(66)

but certainly the intravenous or intramuscular route
is preferable.
Human Placental Extracts are now commercially available which are very efficacious and undoubtedly depend on the high content of thro mbokinase in this tissue.

It is given intramuscularly preferably, but can

be given orally with good results according to Eley
(82).

If given orally, there must be a fasting period,

as digestive juices destroy its coagulative properties.
This is effective for 72-hour periods, and is used preoperatively particularly in hemophilics; in doses of
one dram three times a day for two days prior to operation and three or f our days post-operatively.
Hanzlik and Weidenthal (83), at Western Reserve
University, have done extensive clinical experimentation on all of t hese thrombokinase preparations and
confirm the above results.

Ferguson (46) and Gold (84)

have independently obtained similar reaultsand feel
that these preparations are definitely valuable in the
indicated deficiency (also 47, 85).
Some of the snake venoms act like thrombokinase
and therefore can be used as a substitute, but their
action will be discussed later with the other snake venoms.
Blood transfusions supply the deficient factor
here also, and in a satisfactory manner, for a period
(67)

of 6-12 hours, but will be discussed later as a 'shotgun' hemostatic.

Deficiencz of Fibrinogen:
The seriousness of conditions which produce a deficiency of fibrinogen, usually leading to death from
causes other than hemorrhage, and their infrequency,
has made commercial fibrinogen preparations of very little value.

They have been prepared and have a reason-

able potency, but can be so infrequently employed to
advantage that they are not distributed.

Much exper-

imental work has been done with these preparations in
order to decrease the coagulation time, but done without
regard to cause of hemorrhage, and naturally, these
experiments showed that administration of fibrinogen
did not produce a shortened coagulation time.

Many so-

called fibrinogen solutions are really thrombokinase in
activity, as they are prepared from tissue extracts
'

(76,86).

Anticoagulants in the Blood:

As has been explained previously, the only demonstrable anticoagulant in the bl_ood is heparin, which is
present in anaphylactic and peptone shock.
it is not one-of the serious problems.

Therefore,

However, Chargaff

and Olson (51) proved that ~rotamine sulfate will de(68)

finitely neutralize the heparin by de-ionizing and therefore flocculatin g it.

The dosage r equired is 50-75%

of the heparin present, and must necessarily be preceded by a determination of the amount of heparin in the
blood.

Substances to Restore Any Deficient factor:
Human whole blood, given intravenously in 200500 cc. quantities, has long been an accepted method
of preventing surgical hemorrhage, as well as treating
hemorrhage.

This serves to add all factors of coag-

ulation and thereby restoring the one which is deficient.

This method is very valuable both in hospital

and general practice, but especially where the physician
does not have the necessary laboratory facilities to
determine the deficiency pre-operatively.

It is more

expensive usually, and less sati sf actory in cases where
a single deficiency is ·great.

It is probably the most

widely used single means of preventing serious hemorrhagic complications fro m surgery, and certainly deserves to hold its i mportant place (83).

A 500 cc.

injec t ion is good for 6-12 hours effect.
A similar attempt is made by the use of serum,
~

human and from other ani mals, and wilh good results

(76,77).

It must be remembered that the prothrombin
(69)

, titre of both · human blood and human serum decreases
by storage by 50% in three weeks, and that it-' makes

.

no -difference whether sodium citrate or citrate dex. trose mixtures a~e used as preservatives (88,89).
Bond and Wright (90) have recently recommended
the use of lyophile serum, its advantages being the
availability and also that the prothrombin titre is
not lost by storage.

Commercial preparations of serum from various animals, usually the ox and horse, are available, and
while they are valuable in some instances, they lose
their prothrombin titre readily and are of no value in
treating a prothrombin deficienqy.

Certaihly with· the

other available substances of known value, horse and
ox serum should not be resorted to.

Hemoplastin (Parke-

Davis and Co.) (81) is a combined serum concentrate
of both ox and horse serum, and is recommended f9r intravenous use in doses of 2-5 cc. The comparative studies of both Aggeler and Lucia, and Pickering and Hemingway showed that it had very little activity (also 105).

Snake Venoms:
Certain of the snake venoms are highly effective
as coagulants.

The action of Russell viper serum is

to transform prothrombin to thrombin, therefore it takes
(70)

the place of thrombokinase.

This indicates its val-

uable effect in hemophilia, where the thrombokinase
is deficient.

It is widely recognized that use of

this serum locally causes immediate clotting at the
site of hemorrhage, when applied as a 1:10,000 solution.

Aggeler and Lucia (76), and Page and Thomas (91)

have both given substantial experimental and clinical
evidence for this.

It has also been used intravenous-

ly and intramuscularly, without any apparent toxic
effect or damage to the vascular walls, or causing extensive intravascular clotting, but the exact dosage
for this method of administration has not yet been satisfactorily worked out, and its use in this manner is
not recommended at present.

Page and Thomas and Hance

(91) both report that they have used it intradermally
in dosage of 0.5 cc. of a 1:100,000 aqueous solution
one-half hour before surgery and no oozing was noticed
on operation.

This venom is dispensed as a dry powder,

in sterile rubber-stoppered vials, 0.1 mg., to which is
added 1 cc. of solvent, resulting in a 1:10,000 solution.
The t i ~ snake and Fer-de-lance (Bothrops atrox)
venoms act like proteolytic enzymes and convert fibrinogen to fibrin directly.

As a temporary measure, this

is very effective as it takes the place of the entire
prothrombin-thrombokinase-calcium complex, and thus

(71)

eliminates the need of many of the normally necessary
factors.

It is then lo gical that i t should be effective

in all types of defective blood coagulation except a
deficiency in fibrinogen, which is very rare.

It has

been very satisfactory both experimentally and clinically as a local hemostatic and much work is being done
now to establish the proper dosage for parenteral use.
Aggeler and Lucia have summarized this work.

Fer-de-

lance venom is dispensed both as a dry, yellow, amorphous powder, and as a 1: 5000 solution in • 85% NaCl.
These preparations offer much hope for an almost universal he mostatic with a . definitely physiologically
sound basis (5,31,76,81).

Other Substances with Olai med He mostatic Properties:
Thrombin:

Warner, Brinkhous, Seegers, .and Smith (13)

best summarize the effectiveness of this agent..

Through

both animal experimentation and clinical work, they found
that when applied locally to operative areas of bleeding
it is very effective, but had no effect when given preoperatively either intramuscularly or intravenously, but
did cause thrombosis and death if given in large doses
intravenously.

Pickering and Hemingway (81) also sub-

stantiate this conclusion.

Protogglin is a commercial

name for thrombin preparation.
(72)

Cephalin likewise proved to be effective locally,
but equally dangerous by intravenous use.

(Pickering

and Hemingway (81), Smith, Warner, and Brinkhous (28).
Kephalin is a tra de name for the c ommercial preparation (92).
Plasma Euglobin:

Euglobin is a substance obtained

by the dialysis of cellular-free c i trated normal human
plasma, which maintains a greatly reduced coagulation
time, when given intravenously every six hours in hemophilics.

Howell has proved this substance is not fib-

rinogen, but it has not been defini tely established
what factor is represented.

Repeated injections pro-

duce no refractive period as results after similar use
of "globuli n substance", obtained by salting out with ·
acid.

Lozner an d Taylor (93) at Harvard University are

responsible for the major work on this substance, but
its place is not defi nitely establ i shed as yet.
Anti-hirudin serum: Orszagh and Alfoldy (94) have
found that by injecting hirudin in g~adually increasing
doses into healthy rabbits, immune substances are produced in this blood plasma, which can be injected into
humans in much s maller doses than normal human plasma
and will shorten the c oa gulation t ime materially.
this fits into the picture is unknown.
(73)

How

Their work has

not been substantiated as yet, and the preparation is
not commercially available.
Ceanothm:

Ceanothyn is said by the manufacturer

to be an extract of the alkaloids of Ceanothus .Americanus
L. , or

11

J ersey Tea.

11

It is said t ·o have been recommend-

ed originally 1n 1836 in the Boston Medical and Surgical Journal, and to have been called a hemostatic by
Hammond in the Georgia Medical Journal in 1879.

Reports

bearing on the chemistry and pharmacology of these alkaloids have been published recently by Groot,(95),
Taylor and Theraldson (96) and none of these workers found
any evidence of coagulant properties.
the most co mmon

1

This is one of

hemostatics 1 used by general practi-

tioners and dentists and many of them have considerable
faith in its use.

Granelli, and Payne have published

independently reports of its successful use ~y them.
The Council on Pharmacy and Chemist ry of the American
Medical Association rejects the claims for the effects
on the coagulation on the coagulat i on process (87).
Tainter and Throndson (77) in their studies of
11

hemostatics 11 which was carried on under standard con-

trol methods found that ma~imum recommended therapeutic doses (30 cc.) failed to shorten the coagulation
time whatsoever.

We must conclude from these findings
(74)

that ceanothyn is of no value in any hemorrhagic
condition and should never be used.
Styptysate:

This is also one of the preparations

that has enjoyed wide use as a hemostatic which is apparently not justified. (77).

This preparation is made

from Capsella bursa-pastoris, or

II

shepherd I s purse 11 ,

and although we know that t h is plant is one source of
Vitamin K, we cannot be sure that this is what - the commercial product contains, as it has apparently never
been analyzed.

It came_ into prominence in Germany dur-

ing the first World War, for the control of uterine
bleeding, as a substitute for ergot.

It then came to

be used by some for control of hemorrhage from other
regions, despite lack of adequate consideration of the
differences in the mechanisms involved in bleeding from
the uterus and in ordinary inj uries.

This co mpound has

repeatedly been the subject for adverse reports by the
Council on Pharmacy and Chemistry of the American Medical Association (97), their experimentations showing
that it had no action on

the coagulation mechanism in

ordinary bleeding.
Koagamin:

This is an oxalic ·acid preparation which

was first made from the oxalis plant and later directly
from purified oxalic acid crystals.
(75)

It was claimed by

Schuman (98), Steinberg and Brown (99) that this preparation was very effective in controlling hemorrhage,
and recommended widely in obstetrical and gynecological journals, in dosage of 3 cc. intravenously, then
2 cc. intramuscularly at three to f our hour intervals,
of a 1 mg. oxalic acid per cc. preparation.

It was

supposed to be effective in fifteen mtnutes and remain effective for eight hours.

There is absolutely

no physi ological basis for possible effect, and these
results have never been verified, s o we must not consider this as a satisfactory hemostatic (also 100).
Sistosan:

This preparation is an extract from

several plants.

The pharmacolo gy and chemistry has

not been investigated, so its action is unknown.

It

is clai med to be effective locally (101), but has never
been used intravenousl y or intramuscularly.

Therefore,

it certa inly does not need considera tion as a preoperative a gent.
Citric Acid:

de Souza and Hoc king (102) inject-

ed citric acid and found that the alkali reserve was
increased and the coagulation of the blo od was shortened.

They reco mmended its use as a hemostatic on that

basis, but further work has proved that patients in an
acidotic c onditi on have a tendency to bleed, and if the
(76)

acid-base balance is normal, there is no bleeding
tendency.

This is practical knowledge only in that

it confirms the warning of adequate control of diabetics preoperative l y.

We may say that citric acid

has no place in a li s t of hemostat i cs.
Glycerol:

Tashiro and Lee (103) found that sod-

ium taurocholate increases the coagulation time, and
that g':lycerol accelerates coagulat i on in jaundice.
Glycerol and sodium taurochoiate are known to be antagonistic and therefore there may be so mephysiologic
basis for the administration of glycerol in jaundiced
patients, but as yet a balance for practical clinical
application has not been reached, ~and its use is therefore not justified.
Pectin and Gelatin have been advocated as aids,
by their value in liver nutrition, but glucose has replaced them.
Tragacanth and Acacia

have often been used in an

atte mp t to increase the viscosity of the blood and
thereby slow the blood flow , so coagulation could take
place.

It is obvi ous, however, that if there is a de-

ficient factor, they are of no value.
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Sex hormones of all types, particularly Colutoid,
(corpus luteum hormone), have been tried, but have been
proven of no value.
Adrenal cortical hormone has been suggested but
its place if any has not been established.
Vaso-constrictors, such as ephedrine are of some
value,as is Vitamin

c,

where there is a defective vas-

cular condition, but these are of no value in defective
coagulation mechanism as such, and since t his paper is
limited to that phase, vascular drugs will .hot be discussed.
Human Milk has been used as a hemostatic both local-

ly and intramuscul arly.

Its action locally must be due

to thrombokinase activity, as it is a cellular product.
How it could act intramuscularly is not known, and it
is not widely used in this manner.
Manetol, Kephrine, Sangostop, Coaguit, Sangoatat,
Zinema~ and Clauden are all commercial preparations,
about which we know nothing of their chemistry or pharmacology, and therefore are not justified in including
them in a group of valuable hemostatics.

(78)

Dietarr. Treatment of Hemorrhagic Disease
The substances involved in normal clotting of
blood when shed are found in relati vely constant amounts.
Deviations from such values favor either bleeding or
clotting depending on a decrease or increase in the concentrations of these substances in the blood, as explained previously.
The chemical nature of the clotting components has
been established as lipins (phospholipids) for the platelets originating in the bone marrow, and globulins for
the prothrombin and fibrinogen synthesized in the liver.
Lipins and globulins are the source of the blood
clotting substances initially arising from the daily
dietary.

This nutritional basis for the composition of

blood in clotting substances has led many workers to
attempt a dietary treatment for certain hemorrhagic diseases.
Bancroft, Stanley-Brown, and Kugelmass (55) studied
two large groups--bleeders whose clotting substances
were decreased in concentration and those tending to
thrombose, in whom the clotting substances were increased in cencentration in the patient's blood.
Bleeders found deficient in fibrinogen or prothrombin were maintained on an acid forming diet high in
(79)

globulins--a protein intake of about five grams per
kilo of body weight.
Bleeders found deficient in platelets were maintained on an acid-forming dietary high in unsaturated
lipins, constituting two-thirds of the caloric intake.
Patients whose clotting index was found high were
maintained on a base-forming dietary consisting of 0.5
gm. per kilo of body weight, fat as contained in the
natural food without addition, and increased fluid intake.
The use of such diets in a series of 225 cases
showed that the clotting factors in the blood could be
readily altered from a deficient amount to normal or
in a reverse manner, and tha t the clotting index changed accordingly.

They found that satisfactory clin-

ical results accompanied these diets.

Experimental

dietary work on dogs verified these results and showed
that 48 hours was a sufficient time to produce a marked
change.
A complete list of sample diets for such condi-

tions and much added evidence for their use can be found
.in the Medical Clinics of North America 19:989-999 (104).
Such dietary treatment has not received widespread
acceptance, but it undoubtedly has some value, as shown
by the work of accepted leaders in this field.
(80)

Most

surgeons would not be satisfied to use such treatment
exclusively since the definite curative value of Vitamin Kand some other hemostatics has been so conclusively proved, but their use as associated therapy should
be worthwhile.

Undoubtedly, with the increasing empha-

sis and knowledge of dietetics in medicine, we can fit
this information into the treatment of the hemorrhagic
case preoperatively.

(81)

Conclusions
We can conclude that the general mechanism of
blood coagulation is understood, and that enough is
known about the factors involved to explain the pathological physiology of their deficiencies, and to classify hemorrhagic diseases on the basis of these deficiencies.

Simple, accurate methods for determining the

presence and extent of these deficiencies have been
worked out by which a hemorrhagic tendency can be predicted preoperatively, and the responsible factor identified, so that rational preventative measures may be
administered.
Substances of curative effect are available for
some of the hemorrhagic conditions, and satisfactory
results for the surgical danger period can be obtained
in all of the hemorrhagic conditions.
widely used so-called

1

Many of the now

hemostatics 1 should be discarded

as they have no physiologic basis for action and no
proven value.

Several substances of known physiologic

action and proven effectiveness will be of value as soon
as the parenteral dosage is determined.

Recent work on effect of diets offers a valuable
adjunct to specific therapy.

(82)
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